0001209191-23-008107.txt : 20230209
0001209191-23-008107.hdr.sgml : 20230209
20230209174352
ACCESSION NUMBER: 0001209191-23-008107
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230207
FILED AS OF DATE: 20230209
DATE AS OF CHANGE: 20230209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Furlong Stephen
CENTRAL INDEX KEY: 0001783360
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38546
FILM NUMBER: 23607591
MAIL ADDRESS:
STREET 1: C/O NEURONETICS, INC.
STREET 2: 3222 PHOENIXVILLE PIKE
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neuronetics, Inc.
CENTRAL INDEX KEY: 0001227636
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3222 PHOENIXVILLE PIKE
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 877-600-7555
MAIL ADDRESS:
STREET 1: 3222 PHOENIXVILLE PIKE
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: NEURONETICS INC
DATE OF NAME CHANGE: 20030416
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-07
0
0001227636
Neuronetics, Inc.
STIM
0001783360
Furlong Stephen
C/O NEURONETICS, INC.
3222 PHOENIXVILLE PIKE
MALVERN
PA
19355
0
1
0
0
CFO
Common Stock
2023-02-07
4
S
0
5584
5.99
D
367685
D
Common Stock
2023-02-08
4
A
0
100000
0.00
A
467685
D
The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award.
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.93 to $6.06. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 8, 2024, in each case subject to continuous service of the Reporting Person through such date.
Each RSU represents a contingent right to receive one share of the Issuer's common stock.
/s/ Stephen Furlong
2023-02-09